Solace Lifesciences, Inc. — Form D
Solace Lifesciences, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2015-05-01. The offering totals $4.0M. Industry: Other Health Care.
Offering
- Filed: 2015-05-01
- Form: D
- Accession: 0001502380-15-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $4.0M
- Remaining: $4.0M
- Minimum investment: $25K
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-239012
Issuer
- Name: Solace Lifesciences, Inc.
- CIK: 0001502380
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 501 SILVERSIDE ROAD #7, WILMINGTON, DE, 19809
- Phone: 877-668-2256
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| James M Poole | Director | Wilmington, DE |
| James M Poole | Executive Officer | Wilmington, DE |
| Stephen G Kujawa | Director | Wilmington, DE |
| David G Pilzner | Director | Wilmington, DE |
| Christopher G Gross | Director | Wilmington, DE |
| Christopher G Gross | Executive Officer | Wilmington, DE |
| Garrett G Holloway | Director | Wilmington, DE |
| Christopher C Gross | Director | Wilmington, DE |
| Christopher C Gross | Executive Officer | Wilmington, DE |
| Garrett C Holloway | Director | Wilmington, DE |
| David C Pilzner | Director | Wilmington, DE |
| Stephen C Kujawa | Director | Wilmington, DE |
| David C Allen | Director | Kerrville, TX |
Other filings by this issuer (3)
More